S.Korea sees release of generic diabetes drugs after Forxiga patent expires

South Korea's pharmaceutical companies are competing to sell generic drugs to raise their presence on the domestic market for diabetes treatment wit...
South Korea's pharmaceutical companies are competing to sell generic drugs to raise their presence on the domestic market for diabetes treatment wit...
JW Pharmaceutical Co. has become the first South Korean drug maker to develop the generic version of a next-generation antibiotic substance, the med...
"When life gets too hard, this is the pharmaceutical company stock you must buy," advises the title of Hanwha Securities' recent research note on Wh...